Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advanced Therapies Inc.

Latest From Advanced Therapies Inc.

EU publishes Regulation on advanced therapies certification

An EU Regulation intended to encourage research into advanced therapies by micro, small and medium-size enterprises (SMEs) has been published in the Official Journal and is expected to enter force next week.


AIFA's new board takes its seats in Italy

The Italian government said that its reorganisation of AIFA, the national medicines regulatory agency, is nearly complete as a new board of directors was installed yesterday.

Italy Regulation

Spain to ease clinical trials of advanced therapies

Independent researchers and researchers investigating advanced therapies in Spain should find it easier to gain approval for clinical trials thanks to a new support office, says the health ministry.


Good news for advanced therapies, bad news for an old painkiller

It's been a busy week for the European Medicines Agency. Not only has it recommended marketing approval of the first advanced therapy product under the new regulatory framework, it has also finally decided that all drugs containing the opioid painkiller dextropropoxyphene should be withdrawn for safety reasons.

Orthopedics Sweden
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Other Names / Subsidiaries